Parathyroid Hormone Derivative with Reduced Osteoclastic Activity Promoted Bone Regeneration via Synergistic Bone Remodeling and Angiogenesis
Abstract
Osteogenesis, osteoclastogenesis, and angiogenesis are the most important processes in bone repair. Parathyroid hormone (PTH) has pro‐osteogenic, pro‐osteoclastogenic, and proangiogenic effects and may be a candidate for use in bone defect repair. However, the local application of PTH to bone defects is counterproductive due to its excessive osteoclastic and bone resorptive effects. In this study, a PTH derivative, PTHrP‐2, is developed that can be applied to local bone defects. First, a modified peptide with a calcium‐binding repeat glutamine tail undergoes controlled local release from a ceramic material and is shown to be a better fit for the repair process than the unmodified peptide. Second, the modified peptide is shown to have strong pro‐osteogenic activity due to mineralization and its facilitation of serine (Ser) phosphorylation. Third, the modified peptide is shown to maintain the pro‐osteoclastogenic and proangiogenic properties of the unmodified peptide, but its pro‐osteoclastogenic activity is reduced compared to that of the unmodified peptide. The reduced pro‐osteoclastogenic and increased pro‐osteogenic properties of the modified peptide reverse the imbalance between osteoblasts and osteoclasts with local PTH application and shift bone resorption to bone regeneration.Keywords
Funding Information
- National Natural Science Foundation of China (81871752, 81301538, 81572178)
This publication has 34 references indexed in Scilit:
- Bone induction by surface-double-modified true bone ceramicsin vitroandin vivoBiomedical Materials, 2013
- Designing Regenerative Biomaterial Therapies for the ClinicScience Translational Medicine, 2012
- Evaluating the feasibility of utilizing the small molecule phenamil as a novel biofactor for bone regenerative engineeringJournal of Tissue Engineering and Regenerative Medicine, 2012
- The use of injectable sonication-induced silk hydrogel for VEGF165 and BMP-2 delivery for elevation of the maxillary sinus floorBiomaterials, 2011
- Repair of rat cranial bone defects with nHAC/PLLA and BMP‐2‐related peptide or rhBMP‐2Journal of Orthopaedic Research, 2011
- The Regulation of Parathyroid Hormone Secretion and SynthesisJournal of the American Society of Nephrology, 2011
- Preparation and characterization of chitosan microspheres for controlled release of synthetic oligopeptide derived from BMP-2Journal of Microencapsulation, 2009
- Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2Journal of Controlled Release, 2009
- Proteins in Mesoporous SilicatesAngewandte Chemie International Edition, 2008
- Pulsatile release of parathyroid hormone from an implantable delivery systemBiomaterials, 2007